Facebook
Twitter
Telegram
Report an ErrorArena Pharmaceuticals Financial Statements 2011-2024 | ARNA
Annual Financial Statements Arena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.65 B | 4.21 B | 2.26 B | 1.83 B | 1.12 B | 353 M | 363 M | 947 M | 1.49 B | 1.59 B | 246 M |
Shares |
60.8 M | 54.8 M | 49.8 M | 47 M | 33 M | 24.3 M | 24.1 M | 22 M | 21.8 M | 19.7 M | 13.9 M |
Historical Prices |
92.9 | 76.8 | 45.4 | 39 | 34 | 14.2 | 19 | 34.7 | 58.5 | 90.2 | 18.7 |
Net Income |
-616 M | -405 M | 398 M | -29.4 M | -91.4 M | -22.5 M | -108 M | -60.5 M | -19.4 M | -85.5 M | -109 M |
Revenue |
54 K | 319 K | 806 M | 18 M | 21.3 M | 124 M | 38.3 M | 37 M | 81.4 M | 27.6 M | 12.7 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 319 K | - | - | - | 109 M | 25.2 M | 29.2 M | 75.2 M | 23.9 M | 4.62 M |
Operating Income |
-624 M | -427 M | 483 M | -145 M | -92 M | -5.26 M | -104 M | -105 M | -22.9 M | -57.1 M | -82.8 M |
Interest Expense |
4.16 M | 4.52 M | 4.79 M | 5.7 M | 6.12 M | 6.51 M | 6.83 M | 6.92 M | 7.09 M | 9.12 M | 14.3 M |
EBITDA |
-620 M | -423 M | 486 M | -141 M | -87.7 M | 20.4 M | -89.2 M | -96.1 M | -14.8 M | -56.4 M | -78.3 M |
Operating Expenses |
- | 427 M | 324 M | 163 M | 101 M | 97.6 M | 124 M | 134 M | 98.2 M | 81 M | 84 M |
General and Administrative Expenses |
126 M | 103 M | 77.6 M | 47.7 M | 30.3 M | 31.2 M | 36 M | 34.1 M | 31.7 M | 26.2 M | 24.2 M |
All numbers in USD currency
Quarterly Income Statement Arena Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | 61.6 M | 61.1 M | 60.8 M | 59.8 M | 58.6 M | 57.8 M | 52.8 M | 50.2 M | 50.2 M | 49.9 M | 49.7 M | 49.5 M | 49.4 M | 49.4 M | 49.3 M | 40 M | 39.3 M | 37.8 M | 30.2 M | 245 M | 24.3 M | 24.3 M | 24.3 M | 243 M | 243 M | 242 M | 242 M | 236 M | 220 M | 220 M | 220 M | 219 M | 219 M | 218 M | 218 M | 218 M | 217 M | 214 M | 190 M | 164 M | 146 M | 146 M | 143 M | 122 K |
Net Income |
- | - | - | - | - | -196 M | -146 M | -118 M | -122 M | -97.4 M | -84.9 M | -100 M | -88.3 M | -72.9 M | -61.4 M | 620 M | 68.7 M | -34.3 M | -31.8 M | -32 M | -13.7 M | -32.4 M | -23.3 M | -22.1 M | 38.6 M | -12.4 M | -27.2 M | -21.5 M | -30.5 M | -26.4 M | -26.8 M | -24.3 M | -32.1 M | -10.7 M | 7.48 M | -25.3 M | -23.5 M | -17.2 M | 40.1 M | -18.9 M | -21.3 M | -15.5 M | -22.1 M | -26.6 M | -23.7 M | -22.7 M | -22.9 M | -39.9 M |
Revenue |
- | - | - | - | - | - | - | - | 37 K | 20 K | - | 262 K | 3 M | 1.35 M | 1.02 M | 801 M | 8.65 M | 3.57 M | 3.99 M | 1.76 M | 15.4 M | 2.42 M | 1.9 M | 1.66 M | 69.2 M | 19.2 M | 9.51 M | 9.85 M | 7.75 M | 9.14 M | 9.18 M | 12.3 M | 9.19 M | 8.16 M | 12.8 M | 6.81 M | 6.52 M | 3.58 M | 68.9 M | 2.37 M | 1.94 M | 1.48 M | 22 M | 2.19 M | 2.08 M | 3.46 M | 3.26 M | 3.92 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | -194 M | -144 M | -132 M | - | -98.8 M | -87.8 M | -105 M | - | -79.3 M | -68.6 M | 725 M | -44.6 M | -36 M | -33.2 M | -31 M | - | -34.2 M | -23 M | -21.2 M | - | -9.86 M | -26.2 M | -19.2 M | - | -25.2 M | -27 M | -21.7 M | - | -26.2 M | -25.4 M | -23.5 M | - | -19.9 M | 39.9 M | -21 M | - | -19.1 M | 1.86 M | -19.6 M | - | -19.3 M | -20 M | -25.2 M |
Interest Expense |
- | - | - | - | - | 1.03 M | 1.05 M | 1.07 M | - | 1.12 M | 1.14 M | 1.16 M | - | 1.2 M | 1.22 M | 1.24 M | - | 1.42 M | 1.45 M | 1.47 M | - | 1.52 M | 1.54 M | 1.57 M | - | 1.61 M | 1.62 M | 1.68 M | - | 1.68 M | 1.75 M | 1.7 M | - | 1.72 M | 1.74 M | 1.75 M | - | 1.77 M | 1.78 M | 1.79 M | - | 1.8 M | 2.49 M | 3.03 M | - | 3.21 M | 3.18 M | 4.69 M |
EBITDA |
- | - | - | - | - | -194 M | -144 M | -131 M | - | -95.9 M | -85.9 M | -104 M | - | -77 M | -67 M | 725 M | -44.6 M | -33.1 M | -31.3 M | -30 M | - | -31 M | -20.8 M | -20.1 M | - | -2.85 M | -21.5 M | -16.8 M | - | -17.8 M | -22 M | -19.3 M | - | -19.8 M | -21.2 M | -21.5 M | - | -14.1 M | 43.8 M | -19.1 M | - | -12 M | 6.58 M | -17.2 M | - | -11.6 M | -14.8 M | -22.6 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | 30.3 M | 31.9 M | 29.5 M | - | 19 M | 22.9 M | 26.4 M | - | 20.4 M | 18.4 M | 16.6 M | - | 10.8 M | 10.4 M | 11.2 M | - | 7.42 M | 7.15 M | 7.52 M | - | 8.59 M | 8.46 M | 6.92 M | - | 9.03 M | 8.84 M | 8.44 M | - | 8.03 M | 9.13 M | 8.04 M | - | 7.76 M | 8.6 M | 7.25 M | - | 7.39 M | 5.22 M | 6.36 M | - | 6.03 M | 6.08 M | 6.89 M |
All numbers in USD currency